Resilient Healthcare Corp (RSLT) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerResilient Healthcare Corp (RSLT) trades at $0.0033. Resilient Healthcare Corp manufactures and sells health, beauty, and food ingredients, along with vitamins and supplements. The company also transforms edible oils into a free-flowing powder, used in various consumer products. Sector: Healthcare.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for RSLT: RSLT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Resilient Healthcare Corp (RSLT) Healthcare & Pipeline Overview
Resilient Healthcare Corp, based in Las Vegas, focuses on manufacturing and selling health, beauty, and food ingredients, including its innovative 'oil to powder' technology. Serving the nutraceutical, cosmetic, and food sectors, the company operates in a competitive landscape with a negative profit margin of -38.6% and a debt-to-equity ratio of 52.80.
What Is the Investment Thesis for RSLT?
Resilient Healthcare Corp presents a high-risk, high-reward investment opportunity. The company's innovative 'oil to powder' technology could drive future growth in the nutraceutical and cosmetic sectors. However, the company's negative profit margin of -38.6% and OTC market listing indicate significant financial and operational challenges. A debt-to-equity ratio of 52.80 also warrants careful consideration. Potential investors should closely monitor the company's ability to improve profitability and navigate the complexities of the OTC market. The company's beta of -0.70 suggests a potential inverse correlation to the market, which may offer diversification benefits, but also reflects its unique risk profile. Success hinges on effective commercialization of its technology and strategic partnerships.
Based on FMP financials and quantitative analysis
RSLT Key Highlights
Negative Profit Margin of -38.6% indicates operational inefficiencies or high initial investment costs.
- Gross Margin of 42.1% suggests potential for profitability if operational costs are managed effectively.
- Debt-to-Equity Ratio of 52.80 indicates a moderate level of financial leverage.
- Beta of -0.70 suggests a potential inverse correlation to the market, which may offer diversification benefits.
- The company rebranded from Nutri Pharmaceuticals Research, Inc. in November 2025, signaling a strategic shift.
Who Are RSLT's Competitors?
RSLT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| MGRX Mangoceuticals, Inc. | $0.44 | -9.03% | $7.42M | — |
| DNPUF Sumitomo Pharma Co., Ltd. | $9.79 | 0.00% | $4.39B | — |
| HCTI Healthcare Triangle, Inc. | $0.72 | +3.34% | $10.9M | — |
| KSPHF Kissei Pharmaceutical Co., Ltd. | $24.50 | 0.00% | $1.02B | — |
| SCNX Scienture Holdings, Inc. | $0.16 | -10.33% | $6.45M | — |
| ACON Aclarion, Inc. | $2.38 | -2.46% | $6.86M | — |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.62 | -1.72% | $11.5M | — |
| BEAT HeartBeam, Inc. | $0.43 | +3.72% | $24.1M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RSLT's Key Strengths?
Proprietary 'oil to powder' technology offers a unique selling proposition.
- Diverse application of ingredients across multiple industries.
- Focus on growing health and wellness market.
- Potential for innovation in product formulations.
What Are RSLT's Weaknesses?
Negative profit margin indicates financial challenges.
- OTC market listing suggests higher risk and lower liquidity.
- Limited brand recognition and market presence.
- Dependence on successful commercialization of its technology.
What Are the Key Risks for RSLT?
Negative profit margin may persist, hindering the company's ability to fund growth initiatives.
- Limited financial disclosure and low liquidity associated with OTC market listing.
- Intense competition from established players in the health and wellness market.
- Regulatory hurdles and compliance requirements may delay product development and market entry.
- Dependence on the successful commercialization of its 'oil to powder' technology.
What Are RSLT's Competitive Advantages?
- Proprietary 'oil to powder' technology.
- Potential for formulation innovation.
- Diversified product applications across multiple industries.
- Focus on health and wellness trends.
What Does RSLT Do?
Resilient Healthcare Corp, formerly known as Nutri Pharmaceuticals Research, Inc., rebranded in November 2025 to reflect its expanded focus on healthcare-related products. Headquartered in Las Vegas, Nevada, the company manufactures and sells a diverse range of ingredients, vitamins, and supplements for the health, beauty, and food industries. A key differentiator is its proprietary process for transforming edible oils into a free-flowing powder form. This 'oil to powder' technology allows the company to create ingredients for finished goods such as food, pet food, nutraceuticals, vitamin supplements, cosmetics, and organic household products. The company's products are sold worldwide, targeting both business-to-business and potentially direct-to-consumer markets, though the latter is not explicitly stated. Resilient Healthcare Corp aims to capitalize on the growing demand for innovative ingredients and health-focused products.
What Products and Services Does RSLT Offer?
- Manufactures and sells health ingredients.
- Manufactures and sells beauty ingredients.
- Manufactures and sells food ingredients.
- Sells vitamins and supplements.
- Develops a process to transform edible oils into a free-flowing powder form.
- Supplies ingredients for nutraceuticals.
- Supplies ingredients for cosmetics.
- Supplies ingredients for organic household products.
How Does RSLT Make Money?
- Manufactures ingredients using its 'oil to powder' technology.
- Sells ingredients to manufacturers of food, cosmetics, and nutraceuticals.
- Generates revenue through the sale of vitamins and supplements.
- Potentially generates revenue through direct-to-consumer sales of finished products.
What Industry Does RSLT Operate In?
Resilient Healthcare Corp operates within the healthcare information services and nutraceuticals market, a sector experiencing growth driven by increasing consumer interest in health and wellness. The market is competitive, with established players and emerging companies vying for market share. Resilient Healthcare Corp's 'oil to powder' technology offers a potential competitive advantage, allowing for unique product formulations. However, the company faces competition from firms like DNPUF, HCTI, KSPHF, MGRX, and NNBP, which also operate in the health and wellness space. Success will depend on effective marketing, strategic partnerships, and the ability to scale production efficiently.
Who Are RSLT's Key Customers?
- Food manufacturers
- Pet food manufacturers
- Nutraceutical manufacturers
- Vitamin and supplement manufacturers
- Cosmetic companies
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Resilient Healthcare Corp operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Las Vegas, US. The company is led by CEO Godfrey Yew. RSLT has traded publicly since 2002.
RSLT Financials
RSLT Latest News
No recent news available for RSLT.
RSLT Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for RSLT.
Price Targets
Wall Street price target analysis for RSLT.
RSLT MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for RSLT; grades run from A+ (80-100) to F (below 30).
Leadership: Godfrey Yew
CEO
Godfrey Yew serves as the Chief Executive Officer of Resilient Healthcare Corp. As CEO, he is responsible for the overall strategic direction and operational performance of the company, guiding its efforts in the manufacturing and sale of health, beauty, and food ingredients.
Track Record: Due to the limited information available, Godfrey Yew's specific achievements and strategic decisions as CEO of Resilient Healthcare Corp cannot be assessed. His tenure and impact on the company's milestones are currently unknown. Further information is needed to evaluate his leadership and track record.
RSLT OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Resilient Healthcare Corp may not meet the minimum financial or reporting standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements, increasing the risk of fraud or mismanagement. Investors should exercise extreme caution and conduct thorough due diligence before investing in OTC Other stocks.
- OTC Tier: OTC Other
- Limited financial disclosure increases the risk of investing in RSLT.
- Low liquidity can make it difficult to buy or sell shares at desired prices.
- The OTC Other tier has fewer regulatory requirements, increasing the risk of fraud or mismanagement.
- The company's negative profit margin and debt-to-equity ratio indicate financial instability.
- Dependence on the successful commercialization of its 'oil to powder' technology.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the market demand for the company's products and services.
- Evaluate the company's competitive position and market share.
- Determine the company's capital structure and debt obligations.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a qualified financial advisor before making any investment decisions.
- The company's operation in the health and wellness sector, which has growing consumer demand.
- The company's proprietary 'oil to powder' technology, which offers a unique selling proposition.
- The company's rebranding in November 2025, signaling a strategic shift.
- The company's presence in Las Vegas, Nevada, a recognized business hub.
Resilient Healthcare Corp Healthcare Stock: Key Questions Answered
What do analysts say about RSLT stock?
As of March 16, 2026, there is no available analyst coverage for Resilient Healthcare Corp (RSLT). Given the company's OTC listing and limited financial disclosure, it is not widely followed by analysts. Investors should conduct their own thorough research and due diligence before making any investment decisions.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited information available on the company's financials and operations due to its OTC listing.
- Information on CEO Godfrey Yew's background and track record is limited.